Arbeidsområder
Seksjonssjef for Forskningsadministrasjon (FA) ved Det medisinske fakultet. Overordnet ansvarlig for rådgiving, planlegging og prioritering i FA-seksjonen, i samarbeid med fakultetsledelsen. Ledelse og videreutvikling av medarbeidere i seksjonen.
Seksjonen har ansvar for forskningsadministrasjon innen
- Forskerutdanning
- Rådgivning og støtte knyttet til EUs rammeprogram for forskning
Bakgrunn
- Seksjonssjef, Helsam, Universitet i Oslo, Norge, 2019- 2020
- Vitenskapelig koordinator og Grant Manager Exodiab (Excellence of Diabetes Research in Sweden; Lunds Universitet, Lund, Sverige, 2011 –2019
- Vetenskaplig koordinator CASE, Lunds Universitet, Lund, Sverige, 2011
- Forsker, Rikshospitalet, Oslo, Norge, 2010
- Rådgiver, Folkehelseinstituttet, Oslo, Norge, 2008-2010
- Post doc, Universitet i Oslo, Norge, 2007-2008
- Post doc, stipend from SSMF, Lund Universitet, Lund, Sverige, 2004-2007
- Program-koordinator for NIR, Lunds Universitet, Lund, Sverige, 2001-2004
- Doktorandtjänst, Lunds Universitet, Lund, Sverige, 1994-2000
- Samarbeid med Novo Nordisk, København, Danmark, 1993 - 2000
- Utbildningsbidrag, Lunds Universitet, Lund, Sverige, 1993 - 1994
- La Jolla Institute for Experimental Medicine, La Jolla, CA, USA, 1991 – 1993
- Pharmacia Experimental Medicine, La Jolla, CA, USA, 1989 - 1991
- Examens project and PhD prep kurs Avdeling for Immunologi, Stockholms Universitet, Sverige, 1989
- Prosjekt Parasit immunologi Imperial College, London, UK, 1988
Utdanning
- PhD i Medisinsk Vitenskap med avhandling “Endothelial-Leukocyte Interactions”, Lunds Universitet, Sverige (2000)
- BSc i biologi, Lunds Universitet, Sverige(1989)
Språk
- Norsk: Flytende
- Engelsk: Flytende
- Svensk: Morsmål
- Dansk: God
- Fransk: Basal
- Tysk: Basal
Emneord:
Ledelse,
Strategi,
Forskningsadministrasjon,
Ekstern finansiering,
Forskerstøtte MED
Utvalgte publikasjoner
1. Li MM, Nilsen A, Shi Y, Fusser M, Ding YH, Fu Y, Liu B, Niu Y, Wu YS, Huang CM, Olofsson M, Jin KX, Lv Y, Xu XZ, He C, Dong MQ, Rendtlew Danielsen JM, Klungland A, Yang YG.
ALKBH4-dependent demethylation of actin regulates actomyosin dynamics.
Nat Commun, 2013. 4: p. 1832.
2. Zhou Y, Holmseth S, Hua R, Lehre AC, Olofsson AM, Poblete-Naredo I, Kempson SA, Danbolt NC.
The betaine-GABA transporter (BGT1, slc6a12) is predominantly expressed in the liver and at lower levels in the kidneys and at the brain surface.
Am J Physiol Renal Physiol, 2012. 302(3): p. F316-28.
3. Lehre AC, Rowley NM, Zhou Y, Holmseth S, Guo C, Holen T, Hua R, Laake P, Olofsson AM, Poblete-Naredo I, Rusakov DA, Madsen KK, Clausen RP, Schousboe A, White HS, Danbolt NC.
Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice.
Epilepsy Res, 2011. 95(1-2): p. 70-81.
4. Gautam N, Olofsson AM, Herwald H, Iversen LF, Lundgren-Åkerlund E, Hedqvist P, Arfors KE, Flodgaard H, Lindbom L. (2001).
Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability.
Nature Medicine. Oct; 7(10): 1123-27.
5. Olofsson AM, Vestberg M, Herwald H, Rygaard J, David G, Arfors KE, Linde V, Flodgaard H, Dedio J, Muller-Esterl W, Lundgren-Åkerlund E. (1999).
Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis.
Journal of Clinical Investigation. Oct; 104(7):885-94.
6. Vajkoczy P, Olofsson AM, Lehr HA, Leiderer R, Hammersen F, Arfors KE, Menger MD. (1995).
Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin.
American Journal of Pathology. Jun;146(6): 1397-405.
7. Hansell P, Olofsson AM, Maione TE, Arfors KE, Borgström P. (1995).
Differences in binding of platelet factor 4 to vascular endothelium in vivo and in endothelial cells in vitro.
Acta Physiologica Scandinavica. 154(4): 449-59.
8. Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE. (1995).
Protection from oxidized LDL- induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E.
Circulation. Mar 1; 91(5): 1525-32.
9. Olofsson AM, Arfors KE, Ramezani L, Wolitzky BA, Butcher EC, von Andrian UH. (1994).
E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules.
Blood. Oct15; 84(8): 2749-58.
10. Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. (1994).
P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo.
Laboratory Investigation. Sep; 71(3):380-6.
11. Lundgren-Åkerlund E, Olofsson AM, Berger E, Arfors KE. (1993).
CD11b/CD18-dependent polymorphonuclear leucocyte interaction with matrix proteins in adhesion and migration.
Scandinavian J. of Immunology. May; 37(5):569-74.
12. Rosengren S, Olofsson AM, von Andrian UH, Lundgren-Åkerlund E, Arfors KE. (1991).
Leukotriene B4-induced neutrophil-mediated endothelial leakage in vitro and in vivo.
Journal of Applied Physiology. Oct; 71(4):1322-30.
Publisert
8. aug. 2019 13:20
- Sist endret
23. nov. 2022 12:38
